http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101613403-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb91dfbdc074d99e7ac7d5159d697cdc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f747b77b8f165b10d4abed51c98d69d9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48292
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1658
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1682
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
filingDate 2015-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc9c649723485c73f75f8741e756e226
publicationDate 2016-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101613403-B1
titleOfInvention Drug delivery system by Gelatin Sponge or Gelatin microsphere and Drug delivery system prepared thereby
abstract The present invention relates to a process for preparing a gelatin sponge or a gelatin microsphere containing phosphate buffered saline (PBS) or a phosphate buffer (phosphate buffer) A series of processes for obtaining a predetermined gelatin foam and a post-treatment process of the obtained gelatin foam in order to improve the conventional process in which the morphology of the pre-granulated granules is irregular and not uniform during grinding, The present invention relates to a method for producing a gelatin drug delivery system and a gelatin drug delivery system produced by the method, wherein the gelatin drug delivery system is manufactured to be more stable and more advantageous in shape preservation by detailed setting conditions caused by additional steps, Phosphate buffer or phosphate buffer was added to the foam and the hydrogen ion concentration was increased from neutral to alkaline And then inducing ionic bonding with the therapeutic agent for liver cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11517644-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020087181-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102116710-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220155883-A
priorityDate 2015-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101575563-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9920342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425901710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426152218
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3083992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449993964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712

Total number of triples: 33.